| Health / Medical Topics |
Liposomal c-raf Antisense Oligonucleotide
The liposomal formulation of a c-raf-1 antisense oligonucleotide, with potential antineoplastic activity. Liposomal c-raf antisense oligonucleotide targets the translation initiation site of human c-raf-1 mRNA, thereby blocking the expression and production of Raf-1 protein and thus inhibit tumor cell growth and development. Raf-1 plays a key role in the RAF/MEK/ERK signaling pathway, which regulates mammalian cell proliferation and growth. The liposomal formulation increases the solubility of the c-raf antisense oligonucleotide, thus improving its pharmacodynamic profile. (NCI Thesaurus)
YOU MAY ALSO LIKE
A liposome-encapsulated formulation of the polyene antifungal antibiotic amphotericin B produced by the bacterium Streptomyces nodosus with antifungal activity. Amphotericin B binds…
A drug preparation that contains the active drug inside very tiny, fat-like particles. This form is easier for the body to absorb…
Large invasive neoplasm of adipose origin
A rare cancer of the fat cells.
Lipoprotein lipase (475 aa, ~53 kDa) is encoded by the human LPL gene. This protein is involved in the metabolism of…
The determination of the amount of lipoprotein a present in a sample.
